Showing 61 - 80 results of 808 for search '"mutant"', query time: 0.06s Refine Results
  1. 61

    Altered Mitochondrial Respiration and Other Features of Mitochondrial Function in Parkin-Mutant Fibroblasts from Parkinson’s Disease Patients by William Haylett, Chrisna Swart, Francois van der Westhuizen, Hayley van Dyk, Lize van der Merwe, Celia van der Merwe, Ben Loos, Jonathan Carr, Craig Kinnear, Soraya Bardien

    Published 2016-01-01
    “…However, published results reporting on patient-derived parkin-mutant fibroblasts have been inconsistent. This study aimed to functionally compare parkin-mutant fibroblasts from PD patients with wild-type control fibroblasts using a variety of assays to gain a better understanding of the role of mitochondrial dysfunction in PD. …”
    Get full text
    Article
  2. 62
  3. 63

    Mutagenesis and Identification of Sugarcane Mutants Using Survival on Polyethylene Glycol and Leaf Damage under Managed Water Stress by Napa Weksanthia, Tanapon Chaisan, Wannasiri Wannarat, Songyos Chotchutima, Peeranuch Jompuk

    Published 2021-01-01
    “…Both healthy mutant sugarcane plants (2,086) and non-mutant plants (234) were cultured on the media with 20% PEG for 16 weeks. …”
    Get full text
    Article
  4. 64

    Mutant Prevention Concentrations of Doripenem and Meropenem Alone and in Combination with Colistin (Polymyxin E), Levofloxacin and Tobramycin in Pseudomonas aeruginosa by George G Zhanel, Vibhu Vishisht, Ed Tam, Daryl J Hoban, James A Karlowsky

    Published 2009-01-01
    “…In the present study, the mutant prevention concentration (MPC) of doripenem was examined and compared with meropenem for its ability to prevent resistant mutant selection for P aeruginosa when used alone and in combination with the other antipseudomonal agents colistin (polymyxin E), levofloxacin and tobramycin. …”
    Get full text
    Article
  5. 65

    Naturally Occurring Hepatitis B Virus B-Cell and T-Cell Epitope Mutants in Hepatitis B Vaccinated Children by Yu-Min Lin, Guey-Mei Jow, Shu-Chi Mu, Bing-Fang Chen

    Published 2013-01-01
    “…Several immune-epitope mutants, such as S45T/A, N131T, I194V, and S207N in S, were detected in all isolates. …”
    Get full text
    Article
  6. 66
  7. 67

    Changes in the content of proteins and lipids and in the state of the antioxidant system in mutant forms of <i>Amaranthus cruentus</i> L. by R. M. Taipova, V. N. Nesterov, O. A. Rozentsvet, B. R. Kuluev

    Published 2022-04-01
    “…An increase in salt tolerance compared to the control was observed in mutants No. 2 and No. 3. Mutant No. 2 under salinization demonstrated higher peroxidase activity and mutant No. 3 higher catalase activity; both mutants showed a reduced rate of superoxide anion formation compared to the control.Conclusion. …”
    Get full text
    Article
  8. 68
  9. 69

    Assessment of the quality of life in metastatic colorectal cancer patients with KRAS gene mutant: a case-control study by Fahmideh Bagrezaei, Bahram Pourghassem Gargari, Reza Eghdam Zamiri, Abdolrasoul Safaiyan, Mohammad Alizadeh

    Published 2025-01-01
    “…This research investigated the association between KRAS mutant status and various aspects of QOL in mCRC patients. …”
    Get full text
    Article
  10. 70
  11. 71

    Variation of fatty acid composition in seed oil in the collection of induced oil flax (Linum humile Mill.) mutants by A. V. Tigova, A. I. Soroka

    Published 2018-11-01
    “…The statistical analysis showed significant distinctions between the mutant lines in the biochemical composition of the oil. …”
    Get full text
    Article
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77

    Mutant Prevention Concentration of Ciprofloxacin against Klebsiella pneumoniae Clinical Isolates: An Ideal Prognosticator in Treating Multidrug-Resistant Strains by B. Aditi Priyadarshini, Krishnan Mahalakshmi, Venkatesan Naveen Kumar

    Published 2019-01-01
    “…Fluoroquinolone-resistant Klebsiella pneumoniae poses a therapeutic challenge when implicated in urinary tract infections, pyelonephritis, pneumonia, skin infections, osteomyelitis, and respiratory infections. The mutant prevention concentration (MPC) represents a concentration threshold above which increase of resistant mutants occurs rarely. …”
    Get full text
    Article
  18. 78

    Tetrahydroxy Cyclic Urea-Potent Inhibitor for HIV-1 Protease Wild Type and Mutant Type—A Computational Design by S. Sree Kanth, M. Vijjulatha

    Published 2008-01-01
    “…The designed molecules were compared with the known cyclic urea molecules by performing docking studies on six of wild type protein and three mutant protein varieties and calculating their ADME properties. …”
    Get full text
    Article
  19. 79

    Dihydrotanshinone I enhanced BRAF mutant melanoma treatment efficacy by inhibiting the STAT3/SOX2 signaling pathway by Xing Luo, Yi Duan, Jinwei He, CongGai Huang, Jun Liu, Yifan Liu, Mengdei Xu, Qiong Dai, Zhihui Yang

    Published 2025-01-01
    “…Combining DHT, BRAF inhibitors, and MEK inhibitors can help treat treatment-resistant BRAF mutant melanoma cells. Experimental results both in vitro and in vivo have shown that the combination of DHT and an inhibitor of the MAPK pathway is safer and more successful than using an inhibitor of the MAPK pathway alone when treating BRAF mutant melanoma.…”
    Get full text
    Article
  20. 80